LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Total Debt Summary of LegoChem Biosciences, Inc.

LegoChem Biosciences, Inc.'s latest annual total debt in 2023 was 12.64 Billion KRW , up 3.22% from previous year.
LegoChem Biosciences, Inc.'s latest quarterly total debt in 2024 Q2 was 12.81 Billion KRW , up 5.88% from previous quarter.
LegoChem Biosciences, Inc. reported annual total debt of 12.24 Billion KRW in 2022, down -0.16% from previous year.
LegoChem Biosciences, Inc. reported annual total debt of 12.26 Billion KRW in 2021, up 207.7% from previous year.
LegoChem Biosciences, Inc. reported quarterly total debt of 12.1 Billion KRW for 2024 Q1, down -4.27% from previous quarter.
LegoChem Biosciences, Inc. reported quarterly total debt of 12.19 Billion KRW for 2023 Q1, down -0.4% from previous quarter.

Annual Total Debt Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Total Debt of LegoChem Biosciences, Inc. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	12.64 Billion KRW	3.22%
2022	12.24 Billion KRW	-0.16%
2021	12.26 Billion KRW	207.7%
2020	3.98 Billion KRW	82.47%
2019	2.18 Billion KRW	0.0%
2018	- KRW	-100.0%
2017	15.22 Billion KRW	8.52%
2016	14.02 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	12.81 Billion KRW	5.88%
2024 Q1	12.1 Billion KRW	-4.27%
2023 Q1	12.19 Billion KRW	-0.4%
2023 Q4	12.64 Billion KRW	3.91%
2023 Q3	12.16 Billion KRW	0.15%
2023 Q2	12.14 Billion KRW	-0.41%
2023 FY	12.64 Billion KRW	3.22%
2022 Q3	12.31 Billion KRW	0.01%
2022 Q4	12.24 Billion KRW	-0.55%
2022 Q2	12.31 Billion KRW	0.24%
2022 Q1	12.28 Billion KRW	0.15%
2021 Q3	12.22 Billion KRW	0.0%
2021 Q4	12.26 Billion KRW	0.37%

Peer Total Debt Comparison of LegoChem Biosciences, Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	79.836%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-3038.157%
BINEX Co., Ltd.	53.5 Billion KRW	76.37%
Bioneer Corporation	44.63 Billion KRW	71.676%
Anterogen.Co.,Ltd.	9.74 Billion KRW	-29.809%
MEDIPOST Co., Ltd.	52.33 Billion KRW	75.842%
CrystalGenomics, Inc.	32 Billion USD	60.492%
Helixmith Co., Ltd	20.22 Billion KRW	37.492%
Chabiotech Co.,Ltd.	449.63 Billion KRW	97.188%
Medy-Tox Inc.	82.83 Billion KRW	84.735%
Peptron, Inc.	9.13 Billion KRW	-38.442%
Amicogen, Inc.	149.59 Billion KRW	91.548%
Genexine, Inc.	67.42 Billion KRW	81.248%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	-26.157%
ALTEOGEN Inc.	83.76 Billion KRW	84.906%
PharmaResearch Co., Ltd.	34.3 Billion KRW	63.144%
SillaJen, Inc.	9.69 Billion KRW	-30.395%
JETEMA, Co., Ltd.	130.49 Billion KRW	90.311%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	67.874%
Genomictree Inc.	1.83 Billion KRW	-589.171%
MedPacto, Inc.	8.6 Billion KRW	-46.952%
D&D Pharmatech	8.13 Billion KRW	-55.44%
EASY BIO,Inc.	82.27 Billion KRW	84.633%
GI Innovation, Inc.	3.72 Billion KRW	-239.815%